nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE4B—bipolar disorder	0.788	1	CbGaD
Flavoxate—PDE8A—adrenal cortex—bipolar disorder	0.00341	0.0654	CbGeAlD
Flavoxate—PDE7B—thyroid gland—bipolar disorder	0.00332	0.0636	CbGeAlD
Flavoxate—PDE7A—nervous system—bipolar disorder	0.00319	0.0612	CbGeAlD
Flavoxate—PDE7B—nervous system—bipolar disorder	0.00279	0.0535	CbGeAlD
Flavoxate—PDE8B—thyroid gland—bipolar disorder	0.00264	0.0507	CbGeAlD
Flavoxate—PDE7A—brain—bipolar disorder	0.00244	0.0468	CbGeAlD
Flavoxate—PDE8A—thyroid gland—bipolar disorder	0.00238	0.0456	CbGeAlD
Flavoxate—PDE8B—nervous system—bipolar disorder	0.00222	0.0426	CbGeAlD
Flavoxate—PDE4D—thyroid gland—bipolar disorder	0.00215	0.0413	CbGeAlD
Flavoxate—PDE7B—brain—bipolar disorder	0.00213	0.0409	CbGeAlD
Flavoxate—PDE8B—cerebellum—bipolar disorder	0.00209	0.0401	CbGeAlD
Flavoxate—PDE4C—nervous system—bipolar disorder	0.00206	0.0394	CbGeAlD
Flavoxate—PDE4A—thyroid gland—bipolar disorder	0.00191	0.0365	CbGeAlD
Flavoxate—PDE8A—cerebellum—bipolar disorder	0.00188	0.0361	CbGeAlD
Flavoxate—PDE4D—cerebellum—bipolar disorder	0.0017	0.0327	CbGeAlD
Flavoxate—PDE8B—brain—bipolar disorder	0.0017	0.0326	CbGeAlD
Flavoxate—PDE4C—brain—bipolar disorder	0.00157	0.0302	CbGeAlD
Flavoxate—PDE8A—brain—bipolar disorder	0.00153	0.0293	CbGeAlD
Flavoxate—PDE4A—cerebellum—bipolar disorder	0.00151	0.0289	CbGeAlD
Flavoxate—PDE4D—brain—bipolar disorder	0.00138	0.0265	CbGeAlD
Flavoxate—PDE4A—brain—bipolar disorder	0.00123	0.0235	CbGeAlD
Flavoxate—PDE4B—thyroid gland—bipolar disorder	0.00114	0.0218	CbGeAlD
Flavoxate—PDE4B—nervous system—bipolar disorder	0.000956	0.0183	CbGeAlD
Flavoxate—CHRM2—nervous system—bipolar disorder	0.000949	0.0182	CbGeAlD
Flavoxate—PDE4B—cerebellum—bipolar disorder	0.000899	0.0172	CbGeAlD
Flavoxate—CHRM1—nervous system—bipolar disorder	0.000864	0.0166	CbGeAlD
Flavoxate—PDE4B—brain—bipolar disorder	0.000731	0.014	CbGeAlD
Flavoxate—CHRM2—brain—bipolar disorder	0.000726	0.0139	CbGeAlD
Flavoxate—CHRM1—brain—bipolar disorder	0.00066	0.0127	CbGeAlD
Flavoxate—CHRM1—GPCR downstream signaling—RGS4—bipolar disorder	5.81e-05	0.000363	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DGKH—bipolar disorder	5.81e-05	0.000363	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ADM—bipolar disorder	5.78e-05	0.000361	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—RGS4—bipolar disorder	5.74e-05	0.000358	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—DRD3—bipolar disorder	5.72e-05	0.000357	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NRG1—bipolar disorder	5.68e-05	0.000355	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—DRD3—bipolar disorder	5.65e-05	0.000353	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—HTR2A—bipolar disorder	5.65e-05	0.000353	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TSHB—bipolar disorder	5.64e-05	0.000352	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PDE4B—bipolar disorder	5.64e-05	0.000352	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TACR1—bipolar disorder	5.64e-05	0.000352	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HTR1A—bipolar disorder	5.63e-05	0.000352	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TRPC3—bipolar disorder	5.61e-05	0.00035	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	5.55e-05	0.000347	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—DRD4—bipolar disorder	5.55e-05	0.000347	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TAC1—bipolar disorder	5.54e-05	0.000346	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—HTR2A—bipolar disorder	5.5e-05	0.000344	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	5.48e-05	0.000342	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—DRD4—bipolar disorder	5.48e-05	0.000342	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—GSK3B—bipolar disorder	5.46e-05	0.000341	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HTR2C—bipolar disorder	5.44e-05	0.00034	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—DRD1—bipolar disorder	5.44e-05	0.00034	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—HTR2A—bipolar disorder	5.41e-05	0.000338	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—DRD5—bipolar disorder	5.38e-05	0.000336	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ADM—bipolar disorder	5.35e-05	0.000334	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DRD5—bipolar disorder	5.31e-05	0.000332	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NTRK2—bipolar disorder	5.29e-05	0.00033	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—RGS4—bipolar disorder	5.28e-05	0.00033	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—DRD3—bipolar disorder	5.27e-05	0.000329	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—GSK3A—bipolar disorder	5.24e-05	0.000327	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TSHB—bipolar disorder	5.21e-05	0.000326	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TACR1—bipolar disorder	5.21e-05	0.000326	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—RGS4—bipolar disorder	5.21e-05	0.000325	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—DRD2—bipolar disorder	5.17e-05	0.000323	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—HTR2A—bipolar disorder	5.15e-05	0.000322	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—HTR2A—bipolar disorder	5.12e-05	0.00032	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—DRD4—bipolar disorder	5.11e-05	0.000319	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—DRD2—bipolar disorder	5.11e-05	0.000319	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—GSK3B—bipolar disorder	4.97e-05	0.000311	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—GSK3B—bipolar disorder	4.97e-05	0.000311	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—POMC—bipolar disorder	4.97e-05	0.00031	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—POMC—bipolar disorder	4.93e-05	0.000308	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—POMC—bipolar disorder	4.93e-05	0.000308	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—HTR2A—bipolar disorder	4.91e-05	0.000307	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—INS—bipolar disorder	4.91e-05	0.000306	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—INS—bipolar disorder	4.91e-05	0.000306	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HTR1A—bipolar disorder	4.9e-05	0.000306	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—IL1B—bipolar disorder	4.86e-05	0.000303	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TAC1—bipolar disorder	4.83e-05	0.000301	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ADCY2—bipolar disorder	4.81e-05	0.000301	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TCF7L2—bipolar disorder	4.79e-05	0.000299	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—HTR2A—bipolar disorder	4.77e-05	0.000298	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—DRD2—bipolar disorder	4.76e-05	0.000297	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	4.76e-05	0.000297	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HTR2C—bipolar disorder	4.73e-05	0.000296	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—DRD1—bipolar disorder	4.73e-05	0.000296	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—POMC—bipolar disorder	4.72e-05	0.000295	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	4.7e-05	0.000293	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—HTR2A—bipolar disorder	4.68e-05	0.000292	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HTR1A—bipolar disorder	4.66e-05	0.000291	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NTRK2—bipolar disorder	4.6e-05	0.000288	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TAC1—bipolar disorder	4.59e-05	0.000287	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—DRD3—bipolar disorder	4.58e-05	0.000286	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—GSK3A—bipolar disorder	4.56e-05	0.000285	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—POMC—bipolar disorder	4.51e-05	0.000282	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—DRD1—bipolar disorder	4.5e-05	0.000281	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HTR2C—bipolar disorder	4.5e-05	0.000281	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TRPC3—bipolar disorder	4.49e-05	0.00028	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—DRD4—bipolar disorder	4.45e-05	0.000278	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TRPC3—bipolar disorder	4.43e-05	0.000277	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—GSK3B—bipolar disorder	4.43e-05	0.000277	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—POMC—bipolar disorder	4.4e-05	0.000275	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NTRK2—bipolar disorder	4.38e-05	0.000274	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—INS—bipolar disorder	4.37e-05	0.000273	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—DRD3—bipolar disorder	4.36e-05	0.000273	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—GSK3A—bipolar disorder	4.34e-05	0.000271	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HTR2A—bipolar disorder	4.33e-05	0.00027	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—POMC—bipolar disorder	4.32e-05	0.00027	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HTR1A—bipolar disorder	4.32e-05	0.00027	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NTRK1—bipolar disorder	4.31e-05	0.000269	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—ADM—bipolar disorder	4.28e-05	0.000268	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TAC1—bipolar disorder	4.25e-05	0.000265	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—DRD4—bipolar disorder	4.24e-05	0.000265	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—ADM—bipolar disorder	4.23e-05	0.000264	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—S100B—bipolar disorder	4.19e-05	0.000262	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ADCY2—bipolar disorder	4.19e-05	0.000262	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TSHB—bipolar disorder	4.17e-05	0.000261	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PDE4B—bipolar disorder	4.17e-05	0.000261	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TACR1—bipolar disorder	4.17e-05	0.000261	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TCF7L2—bipolar disorder	4.17e-05	0.000261	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HTR2C—bipolar disorder	4.17e-05	0.00026	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—DRD1—bipolar disorder	4.17e-05	0.00026	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—DRD2—bipolar disorder	4.15e-05	0.000259	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PDE4B—bipolar disorder	4.12e-05	0.000257	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TSHB—bipolar disorder	4.12e-05	0.000257	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TACR1—bipolar disorder	4.12e-05	0.000257	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—GSK3B—bipolar disorder	4.12e-05	0.000257	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—POMC—bipolar disorder	4.11e-05	0.000257	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—POMC—bipolar disorder	4.09e-05	0.000255	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TRPC3—bipolar disorder	4.08e-05	0.000255	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—INS—bipolar disorder	4.06e-05	0.000254	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NTRK2—bipolar disorder	4.05e-05	0.000253	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—DRD3—bipolar disorder	4.04e-05	0.000252	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TRPC3—bipolar disorder	4.03e-05	0.000251	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—GSK3A—bipolar disorder	4.02e-05	0.000251	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ADCY2—bipolar disorder	3.99e-05	0.000249	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TCF7L2—bipolar disorder	3.97e-05	0.000248	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—DRD2—bipolar disorder	3.95e-05	0.000246	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—POMC—bipolar disorder	3.93e-05	0.000245	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—DRD4—bipolar disorder	3.92e-05	0.000245	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ADM—bipolar disorder	3.89e-05	0.000243	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ADM—bipolar disorder	3.84e-05	0.00024	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—POMC—bipolar disorder	3.81e-05	0.000238	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	3.8e-05	0.000237	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PDE4B—bipolar disorder	3.79e-05	0.000237	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TSHB—bipolar disorder	3.79e-05	0.000237	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TACR1—bipolar disorder	3.79e-05	0.000237	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKR1C4—bipolar disorder	3.78e-05	0.000236	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NTRK1—bipolar disorder	3.75e-05	0.000234	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	3.75e-05	0.000234	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PDE4B—bipolar disorder	3.74e-05	0.000234	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TSHB—bipolar disorder	3.74e-05	0.000234	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TACR1—bipolar disorder	3.74e-05	0.000234	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—POMC—bipolar disorder	3.74e-05	0.000233	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKR1C4—bipolar disorder	3.73e-05	0.000233	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NRG1—bipolar disorder	3.7e-05	0.000231	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ADCY2—bipolar disorder	3.69e-05	0.00023	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TCF7L2—bipolar disorder	3.68e-05	0.00023	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—DRD2—bipolar disorder	3.65e-05	0.000228	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—S100B—bipolar disorder	3.65e-05	0.000228	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—HTR2A—bipolar disorder	3.62e-05	0.000226	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—HTR2A—bipolar disorder	3.58e-05	0.000223	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NTRK1—bipolar disorder	3.57e-05	0.000223	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DGKH—bipolar disorder	3.48e-05	0.000217	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—S100B—bipolar disorder	3.47e-05	0.000217	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—POMC—bipolar disorder	3.46e-05	0.000216	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HTR1A—bipolar disorder	3.46e-05	0.000216	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DGKH—bipolar disorder	3.43e-05	0.000214	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HTR1A—bipolar disorder	3.41e-05	0.000213	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TAC1—bipolar disorder	3.4e-05	0.000213	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TAC1—bipolar disorder	3.36e-05	0.00021	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HTR2C—bipolar disorder	3.34e-05	0.000208	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—DRD1—bipolar disorder	3.34e-05	0.000208	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HTR2A—bipolar disorder	3.34e-05	0.000208	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NTRK1—bipolar disorder	3.31e-05	0.000206	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—DRD1—bipolar disorder	3.29e-05	0.000206	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HTR2C—bipolar disorder	3.29e-05	0.000206	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—DRD3—bipolar disorder	3.23e-05	0.000202	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NRG1—bipolar disorder	3.22e-05	0.000201	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—S100B—bipolar disorder	3.21e-05	0.000201	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—DRD3—bipolar disorder	3.19e-05	0.000199	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD5—bipolar disorder	3.18e-05	0.000199	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HTR1A—bipolar disorder	3.14e-05	0.000196	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—DRD4—bipolar disorder	3.14e-05	0.000196	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD5—bipolar disorder	3.14e-05	0.000196	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RGS4—bipolar disorder	3.12e-05	0.000195	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HTR1A—bipolar disorder	3.1e-05	0.000193	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—DRD4—bipolar disorder	3.1e-05	0.000193	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TAC1—bipolar disorder	3.09e-05	0.000193	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RGS4—bipolar disorder	3.08e-05	0.000192	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NRG1—bipolar disorder	3.07e-05	0.000191	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TAC1—bipolar disorder	3.05e-05	0.000191	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HTR2C—bipolar disorder	3.03e-05	0.000189	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—DRD1—bipolar disorder	3.03e-05	0.000189	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HTR2C—bipolar disorder	2.99e-05	0.000187	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DRD1—bipolar disorder	2.99e-05	0.000187	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—ADCY2—bipolar disorder	2.95e-05	0.000184	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—DRD3—bipolar disorder	2.94e-05	0.000183	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—DRD2—bipolar disorder	2.92e-05	0.000183	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—ADCY2—bipolar disorder	2.92e-05	0.000182	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HTR2A—bipolar disorder	2.9e-05	0.000181	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DRD3—bipolar disorder	2.9e-05	0.000181	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—POMC—bipolar disorder	2.89e-05	0.000181	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—DRD2—bipolar disorder	2.89e-05	0.00018	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—POMC—bipolar disorder	2.86e-05	0.000178	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—DRD4—bipolar disorder	2.85e-05	0.000178	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NRG1—bipolar disorder	2.84e-05	0.000177	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DRD4—bipolar disorder	2.81e-05	0.000176	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HTR2A—bipolar disorder	2.76e-05	0.000173	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—GSK3B—bipolar disorder	2.69e-05	0.000168	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ADCY2—bipolar disorder	2.68e-05	0.000168	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—POMC—bipolar disorder	2.66e-05	0.000166	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—DRD2—bipolar disorder	2.65e-05	0.000166	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—INS—bipolar disorder	2.65e-05	0.000165	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ADCY2—bipolar disorder	2.65e-05	0.000165	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DRD2—bipolar disorder	2.62e-05	0.000164	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HTR2A—bipolar disorder	2.56e-05	0.00016	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TRPC3—bipolar disorder	2.41e-05	0.00015	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TRPC3—bipolar disorder	2.38e-05	0.000149	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—GSK3B—bipolar disorder	2.34e-05	0.000146	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—POMC—bipolar disorder	2.32e-05	0.000145	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—INS—bipolar disorder	2.31e-05	0.000144	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADM—bipolar disorder	2.3e-05	0.000144	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADM—bipolar disorder	2.27e-05	0.000142	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDE4B—bipolar disorder	2.24e-05	0.00014	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TACR1—bipolar disorder	2.24e-05	0.00014	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TSHB—bipolar disorder	2.24e-05	0.00014	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—GSK3B—bipolar disorder	2.22e-05	0.000139	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TSHB—bipolar disorder	2.21e-05	0.000138	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDE4B—bipolar disorder	2.21e-05	0.000138	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TACR1—bipolar disorder	2.21e-05	0.000138	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—POMC—bipolar disorder	2.21e-05	0.000138	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—INS—bipolar disorder	2.19e-05	0.000137	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—GSK3B—bipolar disorder	2.06e-05	0.000129	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	2.05e-05	0.000128	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—POMC—bipolar disorder	2.04e-05	0.000128	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—INS—bipolar disorder	2.03e-05	0.000127	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HTR2A—bipolar disorder	2.02e-05	0.000126	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	1.86e-05	0.000116	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	1.85e-05	0.000116	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HTR2A—bipolar disorder	1.84e-05	0.000115	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR1A—bipolar disorder	1.83e-05	0.000114	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TAC1—bipolar disorder	1.83e-05	0.000114	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TAC1—bipolar disorder	1.8e-05	0.000113	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	1.79e-05	0.000112	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD1—bipolar disorder	1.79e-05	0.000112	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR2C—bipolar disorder	1.77e-05	0.00011	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD1—bipolar disorder	1.77e-05	0.00011	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	1.74e-05	0.000109	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD3—bipolar disorder	1.73e-05	0.000108	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	1.73e-05	0.000108	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NTRK2—bipolar disorder	1.72e-05	0.000107	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD3—bipolar disorder	1.71e-05	0.000107	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GSK3A—bipolar disorder	1.7e-05	0.000106	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD4—bipolar disorder	1.68e-05	0.000105	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD4—bipolar disorder	1.66e-05	0.000104	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	1.63e-05	0.000102	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	1.61e-05	0.000101	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	1.58e-05	9.9e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	1.58e-05	9.86e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD2—bipolar disorder	1.57e-05	9.79e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	1.56e-05	9.77e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	1.56e-05	9.73e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD2—bipolar disorder	1.55e-05	9.67e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—POMC—bipolar disorder	1.48e-05	9.27e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—POMC—bipolar disorder	1.47e-05	9.15e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	1.42e-05	8.87e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	1.4e-05	8.75e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—S100B—bipolar disorder	1.38e-05	8.62e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—S100B—bipolar disorder	1.36e-05	8.51e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NRG1—bipolar disorder	1.22e-05	7.61e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NRG1—bipolar disorder	1.2e-05	7.51e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	1.1e-05	6.86e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	1.08e-05	6.77e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	8.84e-06	5.52e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—POMC—bipolar disorder	8.77e-06	5.48e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	8.73e-06	5.45e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—INS—bipolar disorder	8.72e-06	5.45e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—POMC—bipolar disorder	8.66e-06	5.41e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—INS—bipolar disorder	8.61e-06	5.38e-05	CbGpPWpGaD
